Why the study?
Despite international guidelines advising reasoned and conciliatory psych drug prescribing, polypharmacy remains highly prevalent among patients hospitalized in psychiatric institutions.
What is the prevalence and impact of polypharmacy in hospitalized psychiatric patients?
What is the prevalence and impact of polypharmacy in hospitalized psychiatric patients?
Polypharmacy remains highly prevalent in hospitalized psychiatric patients, negatively impacting tolerability, adherence, and healthcare costs.
Answers are grounded in this paper and cite their sources.
May prompt medication reviews in psychiatric inpatients; leaves open whether deprescribing improves outcomes.
Despite international guideline recommendations where reasoned and conciliatory prescription of psych drugs is advised, there is still a high prevalence of polypharmacy in patients hospitalized in psychiatric institutions. In the present study 4 out of 5 patients received polypharmacy decreasing tolerability, treatment adherence and increasing the risk and costs secondary to an increased hospital stay.
No takes yet. Share an insight, caveat, or question.
Carmona et al. (2019) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: